Ranbaxy Laboratories was established early in 1961. The manufacturer is a research-based international pharmaceutical company serving customers in approx. 150 countries and it has eventually experienced more than 50 years in providing high quality, which is affordable medicine that is all trusted by healthcare professionals and patients.

Ranbaxy Laboratories is known for operating in approx. 43 countries and 21 manufacturing facilities that are spread evenly approx. eight countries. The company is known for covering all the top 25 pharmaceutical markets of the world that might have a robust that was present across both developed and emerging markets. Driven by some of the innovation and those might continue focus on research and development (R&D), this manufacturing company has achieved various regulatory approvals in both developed and emerging in the market for serving the needy.

A major part of such effort might have been well-establishment of the company’s own research and development center that was enabled the company so as to begin for entering some new Chemical Entities (NCE) and Novel Drug Delivery Systems (NDDS) markets. In the mid-2000s, the company might have had a number of NCEs in progress, and they might have already launched its first NDDS product, which is a single daily dosage formulation of ciprofloxacin.